In the spring, the U.S. government and the World Health Organization declared an end to the COVID-19 global health emergency.
SCHOTT Pharma see FY 25 impacted by slower growth from syringes – Biotech Investments
SCHOTT Pharma AG & Co. KGaA / Key word(s): Forecast SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma see FY 25 impacted by slower growth